Oncology Clinical Trials in Madison, WI

As of August 2026, 139 paid clinical trials are recruiting for Oncology in Madison, Wisconsin. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 31, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

141 clinical trials for Oncology

·Clear filters·

Email me when a new oncology trial opens in Madison, WI.

Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

for Metastatic Colorectal Cancer

Drug: Bevacizumab

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+

Code: NCT05854498·Phase 2·Recruiting·Listed May 2023

Apply to this trial

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

for Breast Cancer

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+

Code: NCT04573231·Phase 2·Recruiting·Listed Oct 2020

Apply to this trial

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

for Melanoma

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+

Code: NCT06199713·Recruiting·Listed Jan 2024

Apply to this trial

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

for Metastatic Prostate Cancer

Sites in Madison +16 more locations

Sponsor: VA Office of Research and Development

Sex: Male·Age: 18+

Code: NCT05011383·Phase 2·Recruiting·Listed Aug 2021

Apply to this trial

In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)

for Chronic Lymphocytic Leukemia

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT04785989·Recruiting·Listed Mar 2021

Apply to this trial

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

for Acute Myeloid Leukemia

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 7 Months - 21

Code: NCT02508038·Phase 1·Recruiting·Listed Jul 2015

Apply to this trial

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

for Prostate Cancer

Sites in Madison +2 more locations

Sponsor: Duke University

Sex: Male·Age: 18+

Code: NCT06141993·Recruiting·Listed Nov 2023

Apply to this trial

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

for Breast Cancer

Sites in Madison +3 more locations

Sponsor: Ruth O'Regan

Sex: All·Age: 18+

Code: NCT04886531·Phase 2·Recruiting·Listed May 2021

Apply to this trial

PET/CT Characterization of Treatment Resistance

for Prostate Cancer

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: Male·Age: 18+

Code: NCT05647564·Recruiting·Listed Dec 2022

Apply to this trial

Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers

for Metastatic Cancer

Drug: Nivolumab

Sites in Madison +1 more location

Sponsor: University of Chicago

Sex: All·Age: 18+

Code: NCT04295863·Phase 1·Recruiting·Listed Mar 2020

Apply to this trial

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

for Solid Tumors

Sites in Madison +15 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07492680·Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

for Rhabdomyosarcoma

Sites in Madison, Milwaukee +83 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT07466316·Phase 3·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

for Metastatic Colorectal Cancer

Sites in Madison +1 more location

Sponsor: Hoffmann-La Roche

Sex: All·Age: 18+

Code: NCT07416552·Phase 1·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for Small Cell Lung Cancer

Drug: ABBV-706

Sites in Madison +29 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07365241·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

for Hematologic Malignancies

1 location in Madison

Sponsor: University of Wisconsin, Madison

Sex: All·Age: 18 - 80

Code: NCT07285668·Recruiting·Listed Dec 2025

Apply to this trial

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for Endometrial Cancer

Drug: Rilvegostomig

Sites in Madison +47 more locations

Sponsor: AstraZeneca

Sex: Female·Age: 18+

Code: NCT06989112·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for Metastatic Malignant Solid Neoplasm

Sites in Madison +17 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05372614·Phase 1·Recruiting·Listed May 2022

Apply to this trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for Endometrial Cancer

Sites in Madison +10 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT05489211·Phase 2·Recruiting·Listed Aug 2022

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

Sites in Madison +60 more locations

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06496178·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

Conditions in Oncology (Madison, WI)

Solid tumor· 25 Breast cancer· 18 Prostate cancer· 16 Acute myeloid leukemia (AML)· 14 Cancer (any)· 12 Non-small cell lung cancer (NSCLC)· 11 Colorectal cancer· 10 Metastatic prostate cancer· 10 Melanoma· 9 Metastatic breast cancer· 7 Ovarian cancer· 7 Pancreatic cancer· 6 Gastric cancer· 6 Multiple myeloma· 6 Myelodysplastic syndromes (MDS)· 6 Chronic lymphocytic leukemia (CLL)· 5 Hematologic malignancy· 5 HER2-negative breast cancer· 4 Endometrial cancer· 4 Hodgkin lymphoma· 4 Non-Hodgkin lymphoma· 4 Head and neck cancer· 4 HER2-positive breast cancer· 3 Metastatic colorectal cancer· 3 Esophageal cancer· 3 Gastroesophageal junction cancer· 3 Biliary tract cancer· 3 Kidney cancer· 3 Acute lymphoblastic leukemia· 3 Leukemia (other)· 3 Diffuse large B-cell lymphoma (DLBCL)· 3 Osteosarcoma· 3 Neuroblastoma· 3 Lung cancer· 2 Small cell lung cancer· 2 Colon cancer· 2 Fallopian tube cancer· 2 Glioma· 2 Mantle cell lymphoma· 2 Small lymphocytic lymphoma· 2 Thyroid cancer· 2 Sarcoma· 2 Rhabdomyosarcoma· 2 Triple-negative breast cancer· 1 Gastrointestinal cancer· 1 Cervical cancer· 1 Glioblastoma· 1 Brain cancer· 1 Myeloproliferative neoplasm· 1 Ewing sarcoma· 1 Mesothelioma· 1